By: Miles S.B. No. 2455               A BILL TO BE ENTITLED   AN ACT   relating to the medical use of low-THC cannabis by patients with   certain medical conditions.          BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:          SECTION 1.  Section 169.003, Occupations Code, is amended to   read as follows:          Sec. 169.003.  PRESCRIPTION OF LOW-THC CANNABIS. A   physician described by Section 169.002 may prescribe low-THC   cannabis to a patient if:                (1)  the patient is a permanent resident of the state;                (2)  the physician complies with the registration   requirements of Section 169.004; and                (3)  the physician certifies to the department that:                      (A)  the patient is diagnosed with:                            (i)  epilepsy;                            (ii)  a seizure disorder;                            (iii)  multiple sclerosis;                            (iv)  spasticity;                            (v)  amyotrophic lateral sclerosis;                            (vi)  autism;                            (vii)  cancer;                            (viii)  an incurable neurodegenerative   disease;                            (ix)  post-traumatic stress disorder; or                            (x)  Glaucoma;                            (xi)  Human Immunodeficiency Virus;                            (xii)  Acquired Immune Deficiency Syndrome;                            (xiii)  Sickle Cell Disease;                            (xiv)  Alzheimer's Disease; or                            (x)(xv) a medical condition that is approved   for a research program under Subchapter F, Chapter 487, Health and   Safety Code, and for which the patient is receiving treatment under   that program; and                      (B)  the physician determines the risk of the   medical use of low-THC cannabis by the patient is reasonable in   light of the potential benefit for the patient.          SECTION 2.  This Act takes effect September 1, 2023.